- Filed
- Sep 17, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Sep 10, 2024 | 7.68M sh |
| Cash And Equivalents | Q1 2025 · Jul 31, 2024 | $32.64M |
| Cash And Equivalents | Q1 2025 · Apr 30, 2024 | $50.18M |
| Current Liabilities | Q1 2025 · Jul 31, 2024 | $7.47M |
| Current Liabilities | Q1 2025 · Apr 30, 2024 | $7.42M |
| Total Liabilities | Q1 2025 · Jul 31, 2024 | $17.15M |
| Total Liabilities | Q1 2025 · Apr 30, 2024 | $20.39M |
| Current Assets | Q1 2025 · Jul 31, 2024 | $32.88M |
| Current Assets | Q1 2025 · Apr 30, 2024 | $50.44M |
| Total Assets | Q1 2025 · Jul 31, 2024 | $70.19M |
| Total Assets | Q1 2025 · Apr 30, 2024 | $59.9M |
| Shares Diluted | Q1 2025 · Jul 31, 2023 | 12.6M sh |
| Stock Repurchased | Q1 2025 · Jul 31, 2023 | $26.46M |
| Operating Cash Flow | Q1 2025 · Jul 31, 2023 | $342.96K |
| Stockholders Equity restated | Q1 2025 · Jul 31, 2023 | $39.19M |
| Stockholders Equity | Q1 2025 · Apr 30, 2023 | $72.69M |
| Eps Diluted restated | Q1 2025 · Jul 31, 2023 | −$0.54 |
| Eps Basic restated | Q1 2025 · Jul 31, 2023 | −$0.54 |
| Rd Expense | Q1 2025 · Jul 31, 2023 | $104.48K |
| Net Income | Q1 2025 · Jul 31, 2023 | −$3.18M |
| Operating Income | Q1 2025 · Jul 31, 2023 | −$2.08M |
| Revenue | Q1 2025 · Jul 31, 2023 | $0 |